Impact Biomedical initiates research programme to solve the patent cliff

The primary cause of the patent crisis is that most techniques for modifying natural molecules to pharmaceutical grade products are essentially 'played out'

picture of

Breaking News

Bora's Bobby Sheng wins CEO of the Year at CPhI Awards

The winners of the awards were announced via an online ceremony held on the 13th of October 2020

Follicum obtains US patent for peptides

The patent will be formally approved on October 27, 2020

A minefield of risks: selecting safe materials

By some estimates, the average adult makes upward of 35,000 decisions a day. For most of us, many of these decisions ...

How paperless manufacturing can support a virtual workforce environment

Jim Lehane, Operations Director at Zenith Technologies, A Cognizant Company, explains how paperless manufacturing can ...

Symbiosis completes MHRA regulatory inspection

In order to comply with the prevailing UK COVID-19 pandemic response guidelines, the inspection was done by remote ...

Sandia helps safeguard biological data threatened during pandemic

The risk associated with using dated security measures for a modern, automated process is rising in light of current ...

Cleanroom Conference and Manufacturing Chemist Live 2020 to go virtual

The virtual event taking place on 10-11 November 2020 will provide delegates with full access to the Manufacturing ...

Diamond supports GenSight in EMA marketing authorisation application

A decision from the European Medicines Agency is expected in H2 2021

Henry Schein implements TraceLink verification router service

The implementation comes ahead of the November 2020 enforcement deadline for the Drug Supply Chain Security Act (DSCSA) ...

What can the pharmaceutical industry do to ensure it’s ready for a future pandemic?

The COVID-19 pandemic has stretched healthcare suppliers, organisations, governments and medical professionals to their ...

Enhancing clinical trial supply with JTM: part II

In a constantly changing world, the pharmaceutical industry is having to adopt its practices to serve the needs of a ...

Non-clinical safety evaluation of vaccines: accelerating clinical development (part II)

This white paper discusses regulatory expectations for the non-clinical development of vaccines, such as safety, ...

Pharmaseal reaches milestone in crowdfunding campaign

The company was first founded in 2016

Status update on ANDA for generic Advair Diskus (VR315 [US])

Vectura Group, an industry leading inhalation CDMO, confirms the announcement made by its partner Hikma Pharmaceuticals